Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Mid-term results of surgery for chronic thromboembolic pulmonary hypertension Ishida K; Masuda M; Tanaka H; Imamaki M; Katsumata M; Maruyama T; Miyazaki MInteract Cardiovasc Thorac Surg 2009[Oct]; 9 (4): 626-9Pulmonary thromboendarterectomy is an effective surgical treatment for chronic thromboembolic pulmonary hypertension (CTEPH). In this study, we review our short- and mid-term results in the recent series of patients undergoing pulmonary thromboendarterectomy. Twenty-three patients (54+/-12 years) were re-evaluated 7-59 months (mean, 34 months) after surgery. Nine patients were in New York Heart Association functional class II, 11 patients in class III and three patients in class IV. All patients used supplemental oxygen therapy. After surgery, pulmonary hemodynamics were significantly improved: pulmonary vascular resistance (PVR) decreased from 925+/-342 to 337+/-260 dynes x s x cm(-5) (P<0.01); mean pulmonary artery pressure (MPAP) decreased from 47+/-12 to 25+/-10 mmHg (P<0.01). Three patients developed severe residual pulmonary hypertension and one of them died soon after surgery. During the follow-up period there were no deaths, but one recurrence of pulmonary embolism. Nineteen patients (86%) were in New York Heart Association functional class I or II and thirteen patients (59%) were weaned from oxygen therapy. In conclusion, pulmonary thromboendarterectomy provided remarkable early and late results with acceptable hospital mortality rate, normalization of pulmonary hemodynamics, and improvement in clinical functional status with relief of hypoxemia.|*Endarterectomy/adverse effects/mortality[MESH]|*Hemodynamics[MESH]|Adult[MESH]|Aged[MESH]|Blood Pressure[MESH]|Female[MESH]|Humans[MESH]|Hypertension, Pulmonary/etiology/mortality/physiopathology/*surgery[MESH]|Hypoxia/etiology/physiopathology/surgery[MESH]|In Vitro Techniques[MESH]|Middle Aged[MESH]|Oxygen Inhalation Therapy[MESH]|Pulmonary Artery/physiopathology/*surgery[MESH]|Recovery of Function[MESH]|Recurrence[MESH]|Severity of Illness Index[MESH]|Thromboembolism/complications/mortality/physiopathology/*surgery[MESH]|Time Factors[MESH]|Treatment Outcome[MESH]|Vascular Resistance[MESH]|Young Adult[MESH] |